Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib

J Am Acad Dermatol. 2011 May;64(5):996-8. doi: 10.1016/j.jaad.2009.08.024.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Alopecia / chemically induced*
  • Alopecia / pathology
  • Carcinoma, Non-Small-Cell Lung / secondary*
  • Cicatrix
  • Drug Eruptions / etiology*
  • ErbB Receptors / antagonists & inhibitors*
  • Erlotinib Hydrochloride
  • Female
  • Humans
  • Lung Neoplasms / pathology
  • Quinazolines / adverse effects*
  • Quinazolines / therapeutic use

Substances

  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors